Trial
NCT02659150
Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
Brigham and Women's Hospital; Genentech, Inc.
Condition
Rheumatoid Arthritis
Intervention
tocilizumab
Why stopped
Terminated by sponsor owing to slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-23